We expect investors to focus on Beam Therapeutics’ BEAM progress in developing its pipeline candidates, which are being ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Beam Therapeutics Inc. before investing. In this article, we go over a few key ...

Beam Therapeutics (BEAM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price ...

Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) was the recipient of some unusual options trading activity on Tuesday.Investors acquired 10,060 put options on the company. This is an ...

Beam Therapeutics Inc. (NASDAQ:BEAM) on Saturday presented additional data from the Phase 1/2 clinical trial of BEAM-302 in patients with alpha-1 antitrypsin deficiency (AATD) at the 2025 Alpha-1 ...

Beam Therapeutics (NASDAQ:BEAM – Get Free Report) was upgraded by equities research analysts at Bank of America from a “neutral” rating to a “buy” rating in a report released on Friday ...

The proton beam therapy center will be Penn's fourth when it opens in late 2027. The others are at HUP, Virtua Voorhees, and ...